Premium
Comment on: Langerhans cell histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinib
Author(s) -
Vicenzi Paige,
Ray Anish
Publication year - 2021
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.28776
Subject(s) - trametinib , medicine , langerhans cell histiocytosis , mek inhibitor , dabrafenib , cancer research , oncology , melanoma , mapk/erk pathway , vemurafenib , genetics , signal transduction , biology , metastatic melanoma , disease